Promedius
PrivateLast Round
Series B
Jun 5, 2026
Total Funding Raised
$25.2M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Promedius is a healthtech company that provides an AI-powered platform using chest X-ray images to screen for osteoporosis and assist in diagnosis.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Imaging, Healthcare Analytics, Computer Vision
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Promedius Comparables
Compare Promedius with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AZmed | 82% | |
| DeepRad AI | 81% | |
| Soombit.ai Inc | 81% |
Promedius Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 5, 2026 | ||||
| Grant | Sep 16, 2025 | ||||
| Series A Extension | Mar 12, 2024 | ||||
| Series A Extension | Oct 21, 2021 | ||||
| Grant | Sep 1, 2020 | ||||
Seed | Jun 30, 2020 |
Key People
Founding team and executive leadership
Promedius Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SL Investment | Series B |
| CNT Tech | Grant |
| Stassets Investment | Series A Extension |
| Korea Investment Partners | Series A Extension |
| STASSETS INVESTMENT | Series B, Series A Extension |
| Woori Venture Partners Co., Ltd. | Series B, Series A Extension |
| Bigbang Angels, Inc. | Grant, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 5, 2026
$14.15M round with participation from Naver Corporation.
- Jan 1, 2026
Launched Osteo Signal, an AI for osteoporosis screening from chest X-rays.
Promedius Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Promedius's valuation, stock price, and market status.
Is Promedius a public or private company?
Promedius is a private company.
What is the current stock price of Promedius?
Promedius is a private company with no public stock price. No recent secondary market data is available.
How much is Promedius worth (valuation)?
Valuation information for Promedius is not publicly available.
Can I buy Promedius stock?
Promedius shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Promedius's last funding round?
Promedius's most recent funding round was Series A Extension on March 12, 2024.
Who are the main investors in Promedius?
Key investors in Promedius include Stassets Investment.
Will Promedius IPO soon?
No public IPO plans have been announced for Promedius.
How can I track Promedius secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Promedius's secondary market activity and sign up for updates.